Paradigm Financial Partners, LLC Bristol Myers Squibb CO Transaction History

Paradigm Financial Partners, LLC

$708 Million
Q3 2024

A detailed history of Paradigm Financial Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 7,893 shares of BMY stock, worth $443,744. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,893

Previous 7,273 8.52%

Holding current value

$443,744

Previous $302,000 35.1%

% of portfolio

0.06%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $24,589 - $32,085	620 Added 8.52%	7,893 $408,000
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $45,241 - $59,560	1,124 Added 18.28%	7,273 $302,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $71,634 - $81,219	1,493 Added 32.07%	6,149 $333,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $12,459 - $14,867	-257 Reduced 5.23%	4,656 $238,000
Q3 2023 Oct 12, 2023	SELL	$57.89 - $64.73 $2,199 - $2,459	-38 Reduced 0.77%	4,913 $285,000
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $17,775 - $19,736	-279 Reduced 5.33%	4,951 $316,000
Q1 2023 Apr 11, 2023	SELL	$65.71 - $74.53 $2,496 - $2,832	-38 Reduced 0.72%	5,230 $362,000
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $2,602 - $3,081	-38 Reduced 0.72%	5,268 $0
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $35 - $21,207	-276 Reduced 4.94%	5,306 $373,000
Q2 2022 Jul 27, 2022	SELL	$72.62 - $79.98 $133,402 - $146,923	-1,837 Reduced 24.76%	5,582 $419,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $30,678 - $36,786	-499 Reduced 6.3%	7,419 $559,000
Q4 2021 Feb 18, 2022	SELL	$53.63 - $62.52 $2.18 Million - $2.54 Million	-40,657 Reduced 83.7%	7,918 $494,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $2.23 Million - $2.6 Million	41,574 Added 593.83%	48,575 $3.03 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $995,949 - $1.17 Million	-16,832 Reduced 70.62%	7,001 $413,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $155,579 - $169,426	-2,513 Reduced 9.54%	23,833 $1.59 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $162,294 - $182,533	-2,735 Reduced 9.4%	26,346 $1.66 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $88,168 - $99,911	-1,527 Reduced 4.99%	29,081 $1.81 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $60,129 - $66,631	-1,047 Reduced 3.31%	30,608 $1.85 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.33 Million - $1.55 Million	24,179 Added 323.42%	31,655 $1.91 Million
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $173,536 - $252,188	3,740 Added 100.11%	7,476 $435,000
Q4 2019 Jan 29, 2020	SELL	$49.21 - $64.19 $51,621 - $67,335	-1,049 Reduced 21.92%	3,736 $240,000
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $14,499 - $17,190	339 Added 7.62%	4,785 $243,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $16,777 - $18,551	-376 Reduced 7.8%	4,446 $202,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $36,547 - $43,578	810 Added 20.19%	4,822 $230,000
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $195,625 - $253,678	4,012 New	4,012 $209,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.

Account

Paradigm Financial Partners, LLC Bristol Myers Squibb CO Transaction History